Chestnut Pharmaceuticals

About Chestnut Pharmaceuticals

Chestnut Pharma is seeking a cure for metastatic cancers. The company is targeting their oncology therapeutics toward a ‘master switch’ they discovered that enables cancer cells to undergo a major cellular transition to adopt an aggressive state and become metastatic while impairing the immune system through several distinct mechanisms.
YEAR FOUNDED
2015
LEADERSHIP:
Co-founder & President Marina Chan Ph.D.
Co-founder & Chief Scientist Taran Gujral Ph.D.
Co-founder & Advisor Marc Kirschner Ph.D.
Co-founder & Advisor Gavin MacBeath Ph.D.